期刊
CA-A CANCER JOURNAL FOR CLINICIANS
卷 66, 期 4, 页码 326-336出版社
WILEY
DOI: 10.3322/caac.21333
关键词
active surveillance; high risk; multiparametric magnetic resonance imaging (MRI); prostate cancer
类别
资金
- NIH
Imaging has traditionally played a minor role in the diagnosis and staging of prostate cancer. However, recent controversies generated by the use of prostate-specific antigen (PSA) screening followed by random biopsy have encouraged the development of new imaging methods for prostate cancer. Multiparametric magnetic resonance imaging (mpMRI) has emerged as the imaging method best able to detect clinically significant prostate cancers and to guide biopsies. Here, the authors explain what mpMRI is and how it is used clinically, especially with regard to high-risk populations, and we discuss the impact of mpMRI on treatment decisions for men with prostate cancer. CA Cancer J Clin 2016;66:326-336. (c) 2015 American Cancer Society
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据